Open Now: The Global ETF Survey Take the Survey →

Advertisement
Advertisement

VHTvsXLVETF Comparison

ETF 1
VHT

Vanguard Health Care ETF

This fund is part of
US Health Care
+2%
VS
ETF 2
XLV

State Street Health Care Select Sector SPDR ETF

This fund is part of
US Health Care
+2%

Vanguard Health Care ETF (VHT) and State Street Health Care Select Sector SPDR ETF (XLV) belong to the same industry segment: US Health Care. VHT's top 3 sector exposures are Healthcare, Consumer Non-Cyclicals and Business Services. In contrast, XLV's top sector exposures are Healthcare, Consumer Non-Cyclicals  VHT is more expensive with a Total Expense Ratio (TER) of 0.09%, versus 0.08% for XLV. VHT is up 8.01% year-to-date (YTD) with -$177M in YTD flows. XLV performs worse with 6.79% YTD performance, and +$229M in YTD flows. Run a side-by-side ETF comparison of VHT and XLV below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.

Find out how industry players manage ETF portfolios.  Discover our library of Model portfolios

VHT vs XLV performance and flow charts

Performance

02468101214%Jun 2Jun 9Jun 16Jun 24Jul 1

Cumulative Flows

0 M200 M400 M600 M800 MJun 2Jun 9Jun 16Jun 24Jul 1

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Historic performance and flows
Data as of 07/02/2026
1M3MYTD1Y3Y5Y
Perf.
VHT
XLV
+13.49%+12.50%
+13.43%+12.13%
+8.01%+6.79%
+25.83%+23.19%
+32.99%+30.86%
+32.43%+38.58%
Flows
VHT
XLV
+$105M+$867M
+$34M-$1.02B
-$177M+$229M
-$537M+$705M
-$2.37B-$6.61B
-$524M+$4.84B
Volatility and drawdown
3M1Y3Y5Y
Volatility
VHT
XLV
+17.16%+17.68%
+15.33%+15.62%
+14.22%+14.21%
+15.33%+14.88%
Max drawdown
VHT
XLV
-4.24%-4.56%
-10.39%-10.51%
-16.88%-17.05%
-17.77%-17.05%
Max drawdown duration
VHT
XLV
32d43d
169d116d
435d444d
767d444d
Trading data

Create an account to view trading data

Join for free
VHT
XLV
Last sale
7/2/2026 at 1:30 PM
$308.41
$163.74
Previous close
07/02/2026
$300.84
$159.54
Consolidated volume
07/02/2026
Average volume
30 days
Average discount or premium
30 days
Average Bid/Ask spread
30 days
Replication quality
Data as of June 30, 2026
1-year trailing difference

Create an account to view replication metrics

Join for free

Create an account to view replication quality

Join for free
VHT
XLV
Tracking error
Tracking difference
1 year cumulative return difference
Best
Worst
Daily return difference
Average
Worst
Advertisement
Main metrics
Last update 7/2/2026 at 1:30 PM
Live
Closed
VHT
XLV
Last price
$308.41
$163.74
1D performance
+2.52%
+2.63%
AuM$18.38 B$42.15 B
E/R0.09%0.08%
Characteristics
VHT
XLV
Management strategyPassivePassive
ProviderVanguardState Street Investment Management
BenchmarkMSCI US IMI Health Care 25/50 IndexS&P Health Care Select Sector Index
N° of holdings42259
Asset classEquitiesEquities
Trailing 12m distribution yield
Join
Join
Inception dateJanuary 26, 2004December 16, 1998
ESGNoNo
Advertisement
Exposure

Countries

VHT
USA
97.01%
Other
2.99%
XLV
USA
97.58%
Other
2.42%

Sectors

VHT
Healthcare
97.65%
Other
2.35%
XLV
Healthcare
97.58%
Other
2.42%
Advertisement

Diversification

VHT

Total weight of top 15 holdings out of 15

61.3%
XLV

Total weight of top 15 holdings out of 15

71.84%

Top 15 holdings

Data as of May 31, 2026
VHT
Eli Lilly & Co.
13.99%
Johnson & Johnson
8.44%
AbbVie, Inc.
6.07%
UnitedHealth Group, Inc.
5.44%
Merck & Co., Inc.
4.63%
Thermo Fisher Scientific, Inc.
2.88%
Amgen, Inc.
2.86%
Gilead Sciences, Inc.
2.63%
Intuitive Surgical, Inc.
2.38%
Abbott Laboratories
2.35%
Pfizer Inc.
2.35%
Bristol Myers Squibb Co.
1.84%
Danaher Corp.
1.83%
CVS Health Corp.
1.82%
Vertex Pharmaceuticals, Inc.
1.79%
XLV
Eli Lilly & Co.
16.19%
Johnson & Johnson
10.04%
AbbVie, Inc.
7.12%
UnitedHealth Group, Inc.
6.37%
Merck & Co., Inc.
5.45%
Thermo Fisher Scientific, Inc.
3.42%
Amgen, Inc.
3.35%
Gilead Sciences, Inc.
3.08%
Intuitive Surgical, Inc.
2.79%
Pfizer Inc.
2.75%
Abbott Laboratories
2.75%
Bristol Myers Squibb Co.
2.15%
CVS Health Corp.
2.14%
Danaher Corp.
2.13%
Vertex Pharmaceuticals, Inc.
2.10%
Frequently asked questions about VHT and XLV

How have the VHT and XLV ETFs performed in 2026?

As of July 2, 2026, VHT is up 8.01% year-to-date (YTD), while XLV has returned 6.79%. That puts VHT better performer ahead so far this year.

Which ETF is attracting more investor money: VHT or XLV?

Year-to-date, the VHT ETF saw -$177M in flows, compared to +$229M for XLV.

Which ETF is more volatile: VHT or XLV?

Over the past year, VHT had a volatility of 15.33%, while XLV experienced 15.62%.

Which ETF is bigger: VHT or XLV?

As of July 2, 2026, VHT holds $18.38 B in assets under management (AUM), while XLV manages $42.15 B.

What sectors do the VHT and XLV ETFs invest in?

VHT leans toward sectors like Healthcare. Meanwhile, XLV focuses on Healthcare.

What are the top holdings of the VHT ETF and XLV ETF?

VHT top holdings include Eli Lilly & Co., Johnson & Johnson and AbbVie, Inc.. XLV holds in its top three: Eli Lilly & Co., Johnson & Johnson and AbbVie, Inc..

Which ETF is more diversified: VHT or XLV?

VHT holds 422 securities with 61.3% of its assets in the top 15. XLV has 59 securities and a top 15 weight of 71.84%.

Advertisement
Advertisement
Advertisement
ETF INVESTOR RESOURCES

Expert-Built ETF Portfolios, All in One Place

Don’t start from scratch. Discover ready-made ETF portfolios built by professionals to match different goals, timelines, and market views. Use them as inspiration or as a starting point for your own allocation.

Portfolio Builder